메뉴 건너뛰기




Volumn 22, Issue 9, 2013, Pages 780-784

Effect of ginkgo biloba extract on visual field progression in normal tension glaucoma

Author keywords

change of progression rate; complementary therapy; Ginkgo biloba extract; normal tension glaucoma

Indexed keywords

BETAXOLOL; BRIMONIDINE; GINEXIN; GINKGO BILOBA EXTRACT; LATANOPROST; UNCLASSIFIED DRUG; ANTIHYPERTENSIVE AGENT; EYE DROPS; GINKGO BILOBA EXTRACT 761; PLANT EXTRACT;

EID: 84890547870     PISSN: 10570829     EISSN: 1536481X     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3182595075     Document Type: Article
Times cited : (53)

References (56)
  • 2
    • 0000083831 scopus 로고
    • The probable involvement of the factors other than intraocular pressure in the pathogenesis of glaucoma
    • In: Drance SM Van Buskirk EM Neufeld AH Eds Baltimore Lippincott Williams and Wilkins
    • Flammer J, Gasser P, Prunte C. The probable involvement of the factors other than intraocular pressure in the pathogenesis of glaucoma. In: Drance SM, Van Buskirk EM, Neufeld AH, eds. Pharmacology of Glaucoma. Baltimore: Lippincott Williams and Wilkins; 1992: 273-283
    • (1992) Pharmacology Of Glaucoma , pp. 273-283
    • Flammer, J.1    Gasser, P.2    Prunte, C.3
  • 3
    • 0032189334 scopus 로고    scopus 로고
    • The effectiveness of intraocular pressure reduction in the treatment of normal-Tension glaucoma
    • Collaborative Normal-Tension Glaucoma Study Group
    • The effectiveness of intraocular pressure reduction in the treatment of normal-Tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126: 498-505
    • (1998) Am J Ophthalmol , vol.126 , pp. 498-505
  • 4
    • 0032189255 scopus 로고    scopus 로고
    • Comparison of glaucomatous progression between untreated patients with normal-Tension glaucoma and patients with therapeutically reduced intraocular pressures
    • Collaborative Normal-Tension Glaucoma Study Group
    • Comparison of glaucomatous progression between untreated patients with normal-Tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126: 487-497
    • (1998) Am J Ophthalmol , vol.126 , pp. 487-497
  • 5
    • 0036822851 scopus 로고    scopus 로고
    • Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial
    • Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002; 120: 1268-1279
    • (2002) Arch Ophthalmol , vol.120 , pp. 1268-1279
    • Heijl, A.1    Leske, M.C.2    Bengtsson, B.3
  • 7
    • 0036023927 scopus 로고    scopus 로고
    • The impact of ocular blood flow in glaucoma
    • Flammer J, Orgul S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21: 359-393
    • (2002) Prog Retin Eye Res , vol.21 , pp. 359-393
    • Flammer, J.1    Orgul, S.2    Costa, V.P.3
  • 8
    • 0025934494 scopus 로고
    • Systemic hypotension: A risk factor for glaucomatous damage?
    • Kaiser HJ, Flammer J. Systemic hypotension: A risk factor for glaucomatous damage? Ophthalmologica. 1991;203: 105-108
    • (1991) Ophthalmologica , vol.203 , pp. 105-108
    • Kaiser, H.J.1    Flammer, J.2
  • 9
    • 82455219161 scopus 로고    scopus 로고
    • Normal tension glaucoma in patients with obstructive sleep apnea/hypopnea syndrome
    • Lin PW, Friedman M, Lin HC, et al. Normal tension glaucoma in patients with obstructive sleep apnea/hypopnea syndrome. J Glaucoma. 2011;20: 553-558
    • (2011) J Glaucoma , Issue.20 , pp. 553-558
    • Lin, P.W.1    Friedman, M.2    Lin, H.C.3
  • 10
    • 33846334841 scopus 로고    scopus 로고
    • Prevalence of normal tension glaucoma in obstructive sleep apnea syndrome patients
    • Sergi M, Salerno DE, Rizzi M, et al. Prevalence of normal tension glaucoma in obstructive sleep apnea syndrome patients. J Glaucoma. 2007;16: 42-46
    • (2007) J Glaucoma , vol.16 , pp. 42-46
    • Sergi, M.1    Salerno, D.E.2    Rizzi, M.3
  • 11
    • 0021363437 scopus 로고
    • Do patients with low tension glaucoma have particular cardiovascular characteristics?
    • Demailly P, Cambien F, Plouin PF, et al. Do patients with low tension glaucoma have particular cardiovascular characteristics? Ophthalmologica. 1984;188: 65-75
    • (1984) Ophthalmologica , vol.188 , pp. 65-75
    • Demailly, P.1    Cambien, F.2    Plouin, P.F.3
  • 12
    • 0015888639 scopus 로고
    • Studies of factors involved in the production of low tension glaucoma
    • Drance SM, Sweeney VP, Morgan RW, et al. Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmol. 1973;89: 457-465
    • (1973) Arch Ophthalmol , vol.89 , pp. 457-465
    • Drance, S.M.1    Sweeney, V.P.2    Morgan, R.W.3
  • 13
    • 0034094018 scopus 로고    scopus 로고
    • Ginkgo biloba extract: Mechanisms and clinical indications
    • Diamond BJ, Shiflett SC, Feiwel N, et al. Ginkgo biloba extract: Mechanisms and clinical indications. Arch Phys Med Rehabil. 2000;81: 668-678
    • (2000) Arch Phys Med Rehabil , vol.81 , pp. 668-678
    • Diamond, B.J.1    Shiflett, S.C.2    Feiwel, N.3
  • 14
    • 80055006038 scopus 로고    scopus 로고
    • Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: A randomized controlled trial
    • In press
    • Ihl R, Bachinskaya N, Korczyn AD, et al. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: A randomized controlled trial. Int J Geriatr Psychiatry. 2010 In press
    • (2010) Int J Geriatr Psychiatry
    • Ihl, R.1    Bachinskaya, N.2    Korczyn, A.D.3
  • 15
    • 0036255603 scopus 로고    scopus 로고
    • The efficacy of Ginkgo special extract EGb 761 in patients with tinnitus
    • Morgenstern C, Biermann E. The efficacy of Ginkgo special extract EGb 761 in patients with tinnitus. Int J Clin Pharmacol Ther. 2002;40: 188-197
    • (2002) Int J Clin Pharmacol Ther , Issue.40 , pp. 188-197
    • Morgenstern, C.1    Biermann, E.2
  • 17
    • 0027959503 scopus 로고
    • Interaction between psychological and pharmacological treatment in cognitive impairment
    • Deberdt W. Interaction between psychological and pharmacological treatment in cognitive impairment. Life Sci. 1994; 55: 2057-2066
    • (1994) Life Sci , vol.55 , pp. 2057-2066
    • Deberdt, W.1
  • 18
    • 0033846696 scopus 로고    scopus 로고
    • Gingko biloba (Rokan) therapy in tinnitus patients and measurable interactions between tinnitus and vestibular disturbances
    • Schneider D, Schneider L, Shulman A, et al. Gingko biloba (Rokan) therapy in tinnitus patients and measurable interactions between tinnitus and vestibular disturbances. Int Tinnitus J. 2000;6: 56-62
    • (2000) Int Tinnitus J. , vol.6 , pp. 56-62
    • Schneider, D.1    Schneider, L.2    Shulman, A.3
  • 19
    • 1642404365 scopus 로고    scopus 로고
    • The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma
    • Hirooka K, Tokuda M, Miyamoto O, et al. The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma. Curr Eye Res. 2004;28: 153-157
    • (2004) Curr Eye Res , vol.28 , pp. 153-157
    • Hirooka, K.1    Tokuda, M.2    Miyamoto, O.3
  • 20
    • 0344867023 scopus 로고    scopus 로고
    • Ginkgo biloba extract increases ocular blood flow velocity
    • Chung HS, Harris A, Kristinsson JK, et al. Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Ther. 1999;15: 233-240
    • (1999) J Ocul Pharmacol Ther , vol.15 , pp. 233-240
    • Chung, H.S.1    Harris, A.2    Kristinsson, J.K.3
  • 21
    • 0026357685 scopus 로고
    • Therapeutic follow-up using automatic perimetry in chronic cerebroretinal ischemia in elderly patients prospective double-blind study with graduated dose ginkgo biloba treatment (egb 761)
    • Raabe A, Raabe M, Ihm P. Therapeutic follow-up using automatic perimetry in chronic cerebroretinal ischemia in elderly patients. Prospective double-blind study with graduated dose Ginkgo biloba treatment (EGb 761). Klin Monbl Augenheilkd. 1991;199: 432-438
    • (1991) Klin Monbl Augenheilkd , vol.199 , pp. 432-438
    • Raabe, A.1    Raabe, M.2    Ihm, P.3
  • 22
    • 0037314489 scopus 로고    scopus 로고
    • Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma
    • discussion 362-354
    • Quaranta L, Bettelli S, Uva MG, et al. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology. 2003;110: 359-362; discussion 362-354
    • (2003) Ophthalmology , vol.110 , pp. 359-362
    • Quaranta, L.1    Bettelli, S.2    Uva, M.G.3
  • 23
    • 0027173798 scopus 로고
    • The lens opacities classification system III the longitudinal study of cataract study group
    • Chylack LT Jr, Wolfe JK, Singer DM, et al. The lens opacities classification system III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111: 831-836
    • (1993) Arch Ophthalmol , vol.111 , pp. 831-836
    • Chylack Jr., L.T.1    Wolfe, J.K.2    Singer, D.M.3
  • 25
    • 0036211639 scopus 로고    scopus 로고
    • Long-Term followup of visual field progression after trabeculectomy in progressive normal-Tension glaucoma
    • Shigeeda T, Tomidokoro A, Araie M, et al. Long-Term followup of visual field progression after trabeculectomy in progressive normal-Tension glaucoma. Ophthalmology. 2002; 109: 766-770
    • (2002) Ophthalmology , vol.109 , pp. 766-770
    • Shigeeda, T.1    Tomidokoro, A.2    Araie, M.3
  • 27
    • 0034116017 scopus 로고    scopus 로고
    • Potential role for Ginkgo biloba extract in the treatment of glaucoma
    • Ritch R. Potential role for Ginkgo biloba extract in the treatment of glaucoma. Med Hypotheses. 2000;54: 221-235
    • (2000) Med Hypotheses , vol.54 , pp. 221-235
    • Ritch, R.1
  • 28
    • 0022958875 scopus 로고
    • Proofs of involvement of PAF-Acether in various immune disorders using BN 52021 (ginkgolide B): A powerful PAF-Acether antagonist isolated from Ginkgo biloba L
    • Braquet P. Proofs of involvement of PAF-Acether in various immune disorders using BN 52021 (ginkgolide B): A powerful PAF-Acether antagonist isolated from Ginkgo biloba L. Adv Prostaglandin Thromboxane Leukot Res. 1986;16: 179-198
    • (1986) Adv Prostaglandin Thromboxane Leukot Res , vol.16 , pp. 179-198
    • Braquet, P.1
  • 29
    • 0023107863 scopus 로고
    • Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man
    • Chung KF, Dent G, McCusker M, et al. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet. 1987;1: 248-251
    • (1987) Lancet , vol.1 , pp. 248-251
    • Chung, K.F.1    Dent, G.2    McCusker, M.3
  • 30
    • 0027081205 scopus 로고
    • Enhancement of hippocampal excitatory synaptic transmission by plateletactivating factor
    • Clark GD, Happel LT, Zorumski CF, et al. Enhancement of hippocampal excitatory synaptic transmission by plateletactivating factor. Neuron. 1992;9: 1211-1216
    • (1992) Neuron , vol.9 , pp. 1211-1216
    • Clark, G.D.1    Happel, L.T.2    Zorumski, C.F.3
  • 32
    • 1842296303 scopus 로고    scopus 로고
    • Antagonistic effects of extract from leaves of Ginkgo biloba on glutamate neurotoxicity
    • Zhu L, Wu J, Liao H, et al. Antagonistic effects of extract from leaves of Ginkgo biloba on glutamate neurotoxicity. Zhongguo Yao Li Xue Bao. 1997;18: 344-347
    • (1997) Zhongguo Yao Li Xue Bao , vol.18 , pp. 344-347
    • Zhu, L.1    Wu, J.2    Liao, H.3
  • 33
    • 2642676874 scopus 로고    scopus 로고
    • Protective effects of Ginkgo biloba extract against lysophosphatidylcholine-induced vascular endothelial cell damage
    • Chen JX, Chen WZ, Huang HL, et al. Protective effects of Ginkgo biloba extract against lysophosphatidylcholine-induced vascular endothelial cell damage. Zhongguo Yao Li Xue Bao. 1998;19: 359-363
    • (1998) Zhongguo Yao Li Xue Bao , vol.19 , pp. 359-363
    • Chen, J.X.1    Chen, W.Z.2    Huang, H.L.3
  • 34
    • 0028338749 scopus 로고
    • The nitric oxide-scavenging properties of ginkgo biloba extract egb 761
    • Marcocci L, Maguire JJ, Droy-Lefaix MT, et al. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761 Biochem Biophys Res Commun. 1994;201: 748-755
    • (1994) Biochem Biophys Res Commun , vol.201 , pp. 748-755
    • Marcocci, L.1    Maguire, J.J.2    Droy-Lefaix, M.T.3
  • 35
    • 0032417316 scopus 로고    scopus 로고
    • Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress-induced platelet aggregation
    • Akiba S, Kawauchi T, Oka T, et al. Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress-induced platelet aggregation. Biochem Mol Biol Int. 1998;46: 1243-1248
    • (1998) Biochem Mol Biol Int , vol.46 , pp. 1243-1248
    • Akiba, S.1    Kawauchi, T.2    Oka, T.3
  • 36
    • 0032989404 scopus 로고    scopus 로고
    • Additional information to the in vitro antioxidant activity of Ginkgo biloba L
    • Lugasi A, Horvahovich P, Dworschak E. Additional information to the in vitro antioxidant activity of Ginkgo biloba L. Phytother Res. 1999;13: 160-162
    • (1999) Phytother Res , vol.13 , pp. 160-162
    • Lugasi, A.1    Horvahovich, P.2    Dworschak, E.3
  • 37
    • 0029989628 scopus 로고    scopus 로고
    • The neuroprotective properties of the Ginkgo biloba leaf: A review of the possible relationship to platelet-Activating factor (PAF)
    • Smith PF, Maclennan K, Darlington CL. The neuroprotective properties of the Ginkgo biloba leaf: A review of the possible relationship to platelet-Activating factor (PAF). J Ethnopharmacol. 1996;50: 131-139
    • (1996) J Ethnopharmacol , vol.50 , pp. 131-139
    • Smith, P.F.1    Maclennan, K.2    Darlington, C.L.3
  • 38
    • 1242341490 scopus 로고    scopus 로고
    • Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD) - A review based on randomized, controlled studies
    • Horsch S, Walther C. Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD) - A review based on randomized, controlled studies. Int J Clin Pharmacol Ther. 2004;42: 63-72
    • (2004) Int J Clin Pharmacol Ther , vol.42 , pp. 63-72
    • Horsch, S.1    Walther, C.2
  • 39
    • 0028275692 scopus 로고
    • Effects of natural antioxidant Ginkgo biloba extract (EGB 761) on myocardial ischemia-reperfusion injury
    • Haramaki N, Aggarwal S, Kawabata T, et al. Effects of natural antioxidant Ginkgo biloba extract (EGB 761) on myocardial ischemia-reperfusion injury. Free Radic Biol Med. 1994;16: 789-794
    • (1994) Free Radic Biol Med , vol.16 , pp. 789-794
    • Haramaki, N.1    Aggarwal, S.2    Kawabata, T.3
  • 40
    • 0030759072 scopus 로고    scopus 로고
    • A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia
    • North American EGb Study Group
    • Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA. 1997;278: 1327-1332
    • (1997) JAMA , vol.278 , pp. 1327-1332
    • Le Bars, P.L.1    Katz, M.M.2    Berman, N.3
  • 41
    • 0032972642 scopus 로고    scopus 로고
    • Effects of EGb761 and superoxide dismutase in an experimental model of retinopathy generated by intravitreal production of superoxide anion radical
    • Baudouin C, Pisella PJ, EttaicheM, et al. Effects of EGb761 and superoxide dismutase in an experimental model of retinopathy generated by intravitreal production of superoxide anion radical. Graefes Arch Clin Exp Ophthalmol. 1999;237: 58-66
    • (1999) Graefes Arch Clin Exp Ophthalmol , vol.237 , pp. 58-66
    • Baudouin, C.1    Pisella, P.J.2    Ettaiche, M.3
  • 42
    • 73849095077 scopus 로고    scopus 로고
    • Protective effects of Ginkgo biloba extract on morphology and function of retinal ganglion cells after optic nerve transection in guinea pigs
    • Xie ZG, Wu XW, Zhuang CR, et al. Protective effects of Ginkgo biloba extract on morphology and function of retinal ganglion cells after optic nerve transection in guinea pigs. Zhong Xi Yi Jie He Xue Bao. 2009;7: 940-946
    • (2009) Zhong Xi Yi Jie He Xue Bao , vol.7 , pp. 940-946
    • Xie, Z.G.1    Wu, X.W.2    Zhuang, C.R.3
  • 43
    • 77954635960 scopus 로고    scopus 로고
    • The effect of Ginkgo biloba on the rat retinal ganglion cell survival in the optic nerve crush model
    • Ma K, Xu L, Zhang H, et al. The effect of Ginkgo biloba on the rat retinal ganglion cell survival in the optic nerve crush model. Acta Ophthalmol. 2010;88: 553-557
    • (2010) Acta Ophthalmol , Issue.88 , pp. 553-557
    • Ma, K.1    Xu, L.2    Zhang, H.3
  • 44
    • 0033560362 scopus 로고    scopus 로고
    • Tutorial in biostatistics an introduction to hierarchical linear modelling
    • Sullivan LM, Dukes KA, Losina E. Tutorial in biostatistics. An introduction to hierarchical linear modelling. Stat Med. 1999;18: 855-888
    • (1999) Stat Med , vol.18 , pp. 855-888
    • Sullivan, L.M.1    Dukes, K.A.2    Losina, E.3
  • 45
    • 38349107673 scopus 로고    scopus 로고
    • A visual field index for calculation of glaucoma rate of progression
    • Bengtsson B, Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol. 2008;145: 343-353
    • (2008) Am J Ophthalmol , vol.145 , pp. 343-353
    • Bengtsson, B.1    Heijl, A.2
  • 46
    • 0030013973 scopus 로고    scopus 로고
    • Analysis of progressive change in automated visual fields in glaucoma
    • Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci. 1996;37: 1419-1428
    • (1996) Invest Ophthalmol Vis Sci , vol.37 , pp. 1419-1428
    • Smith, S.D.1    Katz, J.2    Quigley, H.A.3
  • 47
    • 0021051267 scopus 로고
    • A comparative study of visual field defects seen in patients with low-Tension glaucoma and chronic simple glaucoma
    • Hitchings RA, Anderton SA. A comparative study of visual field defects seen in patients with low-Tension glaucoma and chronic simple glaucoma. Br J Ophthalmol. 1983;67: 818-821
    • (1983) Br J Ophthalmol , vol.67 , pp. 818-821
    • Hitchings, R.A.1    Anderton, S.A.2
  • 48
    • 0021262946 scopus 로고
    • Comparison of visual field defects in the low-Tension glaucomas with those in the high-Tension glaucomas
    • Caprioli J, Spaeth GL. Comparison of visual field defects in the low-Tension glaucomas with those in the high-Tension glaucomas. Am J Ophthalmol. 1984;97: 730-737
    • (1984) Am J Ophthalmol , vol.97 , pp. 730-737
    • Caprioli, J.1    Spaeth, G.L.2
  • 49
    • 0027131608 scopus 로고
    • Visual field defects in normaltension and high-Tension glaucoma
    • Araie M, Yamagami J, Suziki Y. Visual field defects in normaltension and high-Tension glaucoma. Ophthalmology. 1993;100: 1808-1814
    • (1993) Ophthalmology , vol.100 , pp. 1808-1814
    • Araie, M.1    Yamagami, J.2    Suziki, Y.3
  • 50
    • 0028905219 scopus 로고
    • Pattern of visual field defects in normal-Tension and high-Tension glaucoma
    • Araie M. Pattern of visual field defects in normal-Tension and high-Tension glaucoma. Curr Opin Ophthalmol. 1995;6: 36-45
    • (1995) Curr Opin Ophthalmol , vol.6 , pp. 36-45
    • Araie, M.1
  • 51
    • 77958615049 scopus 로고    scopus 로고
    • Normal versus high tension glaucoma: A comparison of functional and structural defects
    • Thonginnetra O, Greenstein VC, Chu D, et al. Normal versus high tension glaucoma: A comparison of functional and structural defects. J Glaucoma. 2010;19: 151-157
    • (2010) J Glaucoma , Issue.19 , pp. 151-157
    • Thonginnetra, O.1    Greenstein, V.C.2    Chu, D.3
  • 52
    • 77949888590 scopus 로고    scopus 로고
    • Visual field progression differences between normal-Tension and exfoliative high-Tension glaucoma
    • Ahrlich KG, De Moraes CG, Teng CC, et al. Visual field progression differences between normal-Tension and exfoliative high-Tension glaucoma. Invest Ophthalmol Vis Sci. 2010;51: 1458-1463
    • (2010) Invest Ophthalmol Vis Sci , Issue.51 , pp. 1458-1463
    • Ahrlich, K.G.1    De Moraes, C.G.2    Teng, C.C.3
  • 53
    • 0033815489 scopus 로고    scopus 로고
    • Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation
    • Membrey WL, Poinoosawmy DP, Bunce C, et al. Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation. Br J Ophthalmol. 2000;84: 1154-1158
    • (2000) Br J Ophthalmol , vol.84 , pp. 1154-1158
    • Membrey, W.L.1    Poinoosawmy, D.P.2    Bunce, C.3
  • 54
    • 78649839026 scopus 로고    scopus 로고
    • Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: Pattern of RNFL defects in glaucoma
    • Leung CK, Choi N, Weinreb RN, et al. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: Pattern of RNFL defects in glaucoma. Ophthalmology. 2010;117: 2337-2344
    • (2010) Ophthalmology , Issue.117 , pp. 2337-2344
    • Leung, C.K.1    Choi, N.2    Weinreb, R.N.3
  • 55
    • 77952480852 scopus 로고    scopus 로고
    • Patterns of progression of localized retinal nerve fibre layer defect on red-free fundus photographs in normal-Tension glaucoma
    • Suh MH, Kim DM, Kim YK, et al. Patterns of progression of localized retinal nerve fibre layer defect on red-free fundus photographs in normal-Tension glaucoma. Eye (Lond). 2010; 24: 857-863
    • (2010) Eye (Lond). , Issue.24 , pp. 857-863
    • Suh, M.H.1    Kim, D.M.2    Kim, Y.K.3
  • 56
    • 10744228958 scopus 로고    scopus 로고
    • Achieving low target pressures with today's glaucoma medications
    • Cantor L. Achieving low target pressures with today's glaucoma medications. Surv Ophthalmol. 2003;48(suppl 1): S8-S16
    • (2003) Surv Ophthalmol , vol.48 , Issue.SUPPL.1
    • Cantor, L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.